Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/1998
05/22/1998WO1998020803A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome
05/22/1998CA2271673A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270772A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome
05/22/1998CA2266890A1 Heterocycle derivatives which inhibit factor xa
05/20/1998EP0842941A1 Novel phosphonates, process for their preparation and pharmaceutical compositions
05/20/1998EP0842185A1 Improved therapeutic agents
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841918A1 Thrombin inhibitors
05/20/1998EP0841911A1 Calcium-containing agent for intestinal phosphate binding and process for producing it
05/20/1998CN1182453A MPL Ligand analogs
05/20/1998CN1182436A Thrombin inhibitors based on the amino acid sequence of hirudin
05/20/1998CN1181972A Medicine for nosohemia and its preparation
05/20/1998CN1181942A Multiple-effect blood-enriching oral liquid
05/20/1998CN1181929A Low-molecular heparin liposome spray preparation and its preparation
05/19/1998US5753706 Methods for treating renal failure
05/19/1998US5753667 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/19/1998US5753635 Purine derivatives and their use as anti-coagulants
05/19/1998US5753632 Administering orally
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753428 Synthetic composition for storage of platelets comprising glycerol
05/19/1998US5753123 Method for purifying thrombomodulin
05/14/1998WO1998020118A1 Modified protein c and methods of use thereof
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019695A1 Device and method for delivery of erythropoietin
05/14/1998WO1998019688A1 Pharmaceutical composition for treatment of diabetes
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/13/1998EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
05/13/1998EP0840740A1 New inhibitors of platelet aggregation
05/13/1998EP0840728A1 Heteroaryl diol acids as leukotriene antagonists
05/13/1998EP0840604A1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
05/13/1998EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
05/13/1998EP0591492B1 A pharmaceutical composition containing a defined lipid system
05/12/1998US5750657 Methods and compositions using fibrin monomer to make a fibrin sealant
05/12/1998US5750572 Anticoagulants
05/12/1998US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
05/12/1998US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors
05/12/1998US5750539 Antiasthmatics
05/12/1998US5750530 Pharmaceutical diketopiperazine compounds
05/12/1998US5750520 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
05/07/1998WO1998018926A1 Circularly permuted erythropoietin receptor agonists
05/07/1998WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS
05/07/1998WO1998018916A1 Human p2x purinoreceptor
05/07/1998WO1998018782A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998WO1998018464A1 Substituted tricyclics
05/07/1998WO1998018456A1 Protease-activated receptor 3 and uses thereof
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998WO1998006747A3 Uses for wnt polypeptides
05/07/1998WO1997046683A3 Polynucleotides encoding secreted proteins
05/07/1998CA2269635A1 Protease-activated receptor 3 and uses thereof
05/07/1998CA2269203A1 Substituted tricyclics
05/07/1998CA2269095A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998CA2268750A1 Human p2x purinoreceptor
05/07/1998CA2268027A1 Novel flt-3 receptor agonists
05/07/1998CA2268001A1 Circularly permuted erythropoietin receptor agonists
05/06/1998EP0839806A1 Substituted tricyclics
05/06/1998EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins
05/06/1998EP0839147A1 New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds
05/06/1998EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
05/06/1998CN1181084A Tricyclic benzazepine vasopression antagonists
05/06/1998CN1181075A Substituted isoxazoles for the treatment of inflammation
05/06/1998CN1181015A Reduction of infarct volume using citicoline
05/06/1998CN1180562A Method for manufacture seaweed acid calcium medicated plaster and seaweed acid calcium fibre nonwoven fabrics
05/06/1998CN1180553A Hemostatic oral liquor
05/05/1998US5747655 Nerve cells, geonomes dna sequences and amino acid sequences
05/05/1998US5747535 Selective thrombin inhibitors
05/05/1998US5747533 Use of ω-3-fatty acids
05/05/1998US5747522 Anticoagulants; antiinflammatory agents; antitumor agents
05/05/1998US5747509 Prevention of occlusion in arteries
05/05/1998US5747496 Inhibitors of platelet aggregation
05/05/1998US5747460 Method of treatment and prophylaxis of venous thrombosis
05/05/1998US5747457 Linear adhesion inhibitors
05/05/1998US5747449 Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
05/05/1998US5747446 Modified polypeptides with increased biological activity
05/05/1998US5747291 Plasmids for production of enzyme urokinase for thrombolytic agents
05/05/1998US5747071 Blood replacements
05/05/1998US5747030 Pharmaceutical preparation containing plasminogen activators
05/05/1998US5747026 Antioxidants
04/1998
04/30/1998WO1998017810A2 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998WO1998017779A1 NOVEL FabH
04/30/1998WO1998017690A1 Receptor specific brain natriuretic peptide (bnp)
04/30/1998WO1998017678A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
04/30/1998WO1998017319A2 Platelet substitutes and conjugation methods suitable for their preparation
04/30/1998WO1998017296A1 Hematopoietic function restorative and processed food both containing treated peanut testae
04/30/1998WO1998017274A1 Thrombin inhibitors
04/30/1998CA2269656A1 Receptor specific brain natriuretic peptide (bnp)
04/30/1998CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists
04/30/1998CA2267260A1 Thrombin inhibitors
04/30/1998CA2263732A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
04/29/1998EP0837883A2 Method of solubilizing, purifying, and refolding protein
04/29/1998EP0734373B1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
04/29/1998CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
04/28/1998US5744584 Antithrombosis agents
04/28/1998US5744457 Compositions and methods for inhibiting thrombogenesis